A source-backed guide to the six categories commonly blurred together in peptide marketing: FDA-approved drugs, compounded medication, investigational drugs, research-use products, longevity protocols, and supplements.
A source-backed guide to checking clinician responsibility, state authority, pharmacy identity, follow-up, escalation, and continuity in online GLP-1 care.
A Mayo Clinic model may make elite medical reasoning available far beyond Rochester. But an answer is not the same thing as care—and an API cannot reorganize a hospital by…
Six hard-stop safety signals and six serious caution flags to check before trusting an online GLP-1 medication offer.
What compounded GLP-1 medication means, why it is not an FDA-approved generic, how shortage rules changed, and what consumers should verify.
A source-backed pre-purchase safety guide for verifying the medication, prescriber, pharmacy, total cost, follow-up, and fulfillment behind an online GLP-1 offer.
A 20-point, source-backed framework for evaluating what a GLP-1 telehealth service discloses about medication identity, clinical accountability, pharmacy source, full cost, follow-up, claims, reviews, and commercial influence.
A practical evidence matrix for checking GLP-1 claims by exact product, approval, population, endpoint, trial design, care accountability, and commercial incentive.
A source-backed verification hub for decoding GLP-1 claims, checking telehealth transparency, understanding compounded-product risks, and finding accountable care.
Sixty-three separate scoreboards grade medical AI. Several are built or maintained by companies with a stake in the results, the scores cannot be compared to each other, and the most…
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.